Bispecific ADCs: Overcoming Tumor Resistance in Oncology
The oncology sector is experiencing a massive leap forward as Bispecific ADCs hit the clinic. While first-generation antibody-drug conjugates proved the viability of targeted chemotherapy, they frequently encountered roadblocks like…